Is there medical evidence that EDTA Oral Chelating Formula is effective?

In a recent clinical trial of heavy-metal urine analysis that was conducted on 14 patients, ages 29 to 73 years, Philip Hoekstra III, Ph.D. measured the effect of Oral Chelating therapy over a six-month period. In addition to noting reductions in levels of aluminum, arsenic, lead and mercury, Hoekstra’s study revealed “marked improvement in blood circulation in all but one of the patients, as documented by the thermologic images.”

Another improvement noted in the study was that “Vascularization (improved blood flow) of the feet increased by as much as 33% — significant improvements after only a six-month trial.”

In a separate study, conducted at Unilab in San Jose, California, researchers analyzed the blood samples of four patients taking Oral Chelating formula. The results showed “significant reductions in total blood cholesterol and triglyceride levels.

The following are the average differences in blood composition from the initiation (baseline) of the protocol until its end at 8 months. Negative values indicate a decrease in the respective constituent after the eight-month time period. All values reported are in mg/dl:

Total Cholesterol: -32.5; Triglycerides: -71; HDL: -0.5;
LDL: -24; VLDL: -8.05; HDL/Total Cholesterol: -0.82

The following are the average changes in blood composition as percentages for the above values:

Total Cholesterol: -16%; Triglycerides: -29%; HDL: -1%; LDL: -18%; VLDL: -16%; HDL/Total Cholesterol: -15%